These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2179424)

  • 1. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources.
    Mobley HL; Chippendale GR
    J Infect Dis; 1990 Mar; 161(3):525-30. PubMed ID: 2179424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urease-positive bacteriuria and obstruction of long-term urinary catheters.
    Mobley HL; Warren JW
    J Clin Microbiol; 1987 Nov; 25(11):2216-7. PubMed ID: 3320089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells.
    Mobley HL; Chippendale GR; Swihart KG; Welch RA
    Infect Immun; 1991 Jun; 59(6):2036-42. PubMed ID: 2037363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR/K hemagglutination of Providencia stuartii correlates with adherence to catheters and with persistence in catheter-associated bacteriuria.
    Mobley HL; Chippendale GR; Tenney JH; Mayrer AR; Crisp LJ; Penner JL; Warren JW
    J Infect Dis; 1988 Feb; 157(2):264-71. PubMed ID: 2891774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli.
    O'Hanley P; Low D; Romero I; Lark D; Vosti K; Falkow S; Schoolnik G
    N Engl J Med; 1985 Aug; 313(7):414-20. PubMed ID: 2862582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteus mirabilis isolates of different origins do not show correlation with virulence attributes and can colonize the urinary tract of mice.
    Sosa V; Schlapp G; Zunino P
    Microbiology (Reading); 2006 Jul; 152(Pt 7):2149-2157. PubMed ID: 16804188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract.
    Zhao H; Li X; Johnson DE; Blomfield I; Mobley HL
    Mol Microbiol; 1997 Mar; 23(5):1009-19. PubMed ID: 9076737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis.
    Li X; Johnson DE; Mobley HL
    Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis.
    Norsworthy AN; Pearson MM
    Trends Microbiol; 2017 Apr; 25(4):304-315. PubMed ID: 28017513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemagglutination of human type O erythrocytes, hemolysin production, and serogrouping of Escherichia coli isolates from patients with acute pyelonephritis, cystitis, and asymptomatic bacteriuria.
    Green CP; Thomas VL
    Infect Immun; 1981 Jan; 31(1):309-15. PubMed ID: 7011993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary pathogenicity of Proteus mirabilis strains isolated from faeces or urine.
    Peerbooms PG; Verweij AM; Oe PL; MacLaren DM
    Antonie Van Leeuwenhoek; 1986; 52(1):53-62. PubMed ID: 3524444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
    Mobley HL; Island MD; Massad G
    Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.
    Johnson DE; Russell RG; Lockatell CV; Zulty JC; Warren JW; Mobley HL
    Infect Immun; 1993 Jul; 61(7):2748-54. PubMed ID: 8514376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection.
    Massad G; Lockatell CV; Johnson DE; Mobley HL
    Infect Immun; 1994 Feb; 62(2):536-42. PubMed ID: 7905463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
    Hola V; Peroutkova T; Ruzicka F
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):343-9. PubMed ID: 22533980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and Catheter-associated bacteriuria and from fecal samples.
    Guyer DM; Kao JS; Mobley HL
    Infect Immun; 1998 Sep; 66(9):4411-7. PubMed ID: 9712795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility.
    Pearson MM; Sebaihia M; Churcher C; Quail MA; Seshasayee AS; Luscombe NM; Abdellah Z; Arrosmith C; Atkin B; Chillingworth T; Hauser H; Jagels K; Moule S; Mungall K; Norbertczak H; Rabbinowitsch E; Walker D; Whithead S; Thomson NR; Rather PN; Parkhill J; Mobley HL
    J Bacteriol; 2008 Jun; 190(11):4027-37. PubMed ID: 18375554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections.
    Dattelbaum JD; Lockatell CV; Johnson DE; Mobley HL
    Infect Immun; 2003 Feb; 71(2):1026-30. PubMed ID: 12540589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract.
    Mobley HL; Chippendale GR; Tenney JH; Hull RA; Warren JW
    J Clin Microbiol; 1987 Dec; 25(12):2253-7. PubMed ID: 2892855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM; Ali MA; Abuo-Rahma GEAA; AbdelAziz N
    Adv Exp Med Biol; 2017; 973():99-113. PubMed ID: 28190143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.